Actively Recruiting
Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)
Led by Jacobs institute · Updated on 2026-03-10
10
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Jacobs Institute is participating in a study designed to collect prospective clinical evidence to evaluate the approved use of the Pipeline™ Flex Embolization Device with Shield Technology™ for the endovascular treatment of adults (22 years of age or older) with wide-necked intracranial aneurysms
CONDITIONS
Official Title
Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults (22 years of age or older) with large or giant wide-necked intracranial aneurysms in the internal carotid artery from the petrous to the superior hypophyseal segments
You will not qualify if you...
- Unable to provide consent or no legally authorized representative available to provide consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Jacobs Institute
Buffalo, New York, United States, 14203
Actively Recruiting
Research Team
C
Carlos Pena, PhD, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here